Kiora Pharmaceuticals Inc financial data

Symbol
KPRX on Nasdaq, KPHMW on OTC
Location
332 Encinitas Boulevard, Suite 102, Encinitas, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 611 % -49.4%
Debt-to-equity 40.8 % +35.5%
Return On Assets -25.8 % -258%
Operating Margin -55.2K % -346268%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.68M shares +22.6%
Common Stock, Shares, Outstanding 3.43M shares +14.4%
Entity Public Float 12.2M USD +157%
Common Stock, Value, Issued 272K USD +1.62%
Weighted Average Number of Shares Outstanding, Basic 4.29M shares +1.78%
Weighted Average Number of Shares Outstanding, Diluted 4.36M shares +3.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Research and Development Expense 9.78M USD +39.1%
General and Administrative Expense 5.61M USD +10.2%
Operating Income (Loss) -8.09M USD -263%
Nonoperating Income (Expense) 976K USD +42.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.11M USD +81.9%
Income Tax Expense (Benefit) 1.43M USD
Net Income (Loss) Attributable to Parent -8.54M USD -254%
Earnings Per Share, Basic -3 USD/shares +36.9%
Earnings Per Share, Diluted -2 USD/shares +65.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.51M USD -2.27%
Accounts Receivable, after Allowance for Credit Loss, Current 1.21M USD -32%
Assets, Current 22.7M USD -28.3%
Property, Plant and Equipment, Net 102K USD +62.6%
Operating Lease, Right-of-Use Asset 318K USD +338%
Intangible Assets, Net (Excluding Goodwill) 6.69M USD 0%
Other Assets, Noncurrent 58.1K USD +94.8%
Assets 29.9M USD -22.5%
Accounts Payable, Current 241K USD -63.4%
Employee-related Liabilities, Current 1.18M USD +14.4%
Accrued Liabilities, Current 2.15M USD +25.7%
Liabilities, Current 2.58M USD -26.9%
Contract with Customer, Liability, Noncurrent 1.25M USD
Deferred Income Tax Liabilities, Net 491K USD -37%
Operating Lease, Liability, Noncurrent 248K USD +533%
Liabilities 7.45M USD -12.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -244K USD -224%
Retained Earnings (Accumulated Deficit) -148M USD -6.14%
Stockholders' Equity Attributable to Parent 22.4M USD -25.4%
Liabilities and Equity 29.9M USD -22.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.7M USD -120%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 2.67M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 3.43M shares +14.4%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -21.3K USD -100%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.51M USD -2.27%
Deferred Tax Assets, Valuation Allowance 13.1M USD -60.2%
Deferred Tax Assets, Gross 14.3M USD -58.5%
Operating Lease, Liability 404K USD +456%
Lessee, Operating Lease, Liability, to be Paid 437K USD +433%
Property, Plant and Equipment, Gross 6.26K USD -56.4%
Operating Lease, Liability, Current 156K USD +366%
Lessee, Operating Lease, Liability, to be Paid, Year Two 137K USD +838%
Lessee, Operating Lease, Liability, to be Paid, Year One 173K USD +521%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 33K USD +254%
Lessee, Operating Lease, Liability, to be Paid, Year Three 85.6K USD +488%
Deferred Tax Assets, Operating Loss Carryforwards 9.24M USD -64.4%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.5K USD
Additional Paid in Capital 170M USD +0.64%
Depreciation, Depletion and Amortization 318 USD -93.5%
Deferred Tax Assets, Net of Valuation Allowance 1.2M USD -20.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%